These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1199 related items for PubMed ID: 19406595

  • 1. PET/CT for the staging and follow-up of patients with malignancies.
    Poeppel TD, Krause BJ, Heusner TA, Boy C, Bockisch A, Antoch G.
    Eur J Radiol; 2009 Jun; 70(3):382-92. PubMed ID: 19406595
    [Abstract] [Full Text] [Related]

  • 2. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
    Metser U, Even-Sapir E.
    Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
    [Abstract] [Full Text] [Related]

  • 3. (18)F-FDG-PET/CT of orofacial tumors, a value of whole-body imaging approach.
    Ferda J, Ferdová E, Záhlava J, Walter J, Mukensnabl P, Daum O, Kreuzberg B.
    Eur J Radiol; 2010 Feb; 73(2):241-8. PubMed ID: 19101104
    [Abstract] [Full Text] [Related]

  • 4. Integrated contrast-enhanced diagnostic whole-body PET/CT as a first-line restaging modality in patients with suspected metastatic recurrence of breast cancer.
    Dirisamer A, Halpern BS, Flöry D, Wolf F, Beheshti M, Mayerhoefer ME, Langsteger W.
    Eur J Radiol; 2010 Feb; 73(2):294-9. PubMed ID: 19181468
    [Abstract] [Full Text] [Related]

  • 5. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
    Schmidt GP, Kramer H, Reiser MF, Glaser C.
    Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
    [Abstract] [Full Text] [Related]

  • 6. Evolving role of 18F-FDG-PET/CT for the body tumor and metastases in pediatrics.
    Chen Z, Li X, Li F, Ouyang Q, Yu T.
    Eur J Radiol; 2010 Sep; 75(3):329-35. PubMed ID: 20576385
    [Abstract] [Full Text] [Related]

  • 7. Comparative study of FDG PET/CT and conventional imaging in the staging of rhabdomyosarcoma.
    Tateishi U, Hosono A, Makimoto A, Nakamoto Y, Kaneta T, Fukuda H, Murakami K, Terauchi T, Suga T, Inoue T, Kim EE.
    Ann Nucl Med; 2009 Feb; 23(2):155-61. PubMed ID: 19225939
    [Abstract] [Full Text] [Related]

  • 8. PET and PET/CT in pediatric oncology.
    Jadvar H, Connolly LP, Fahey FH, Shulkin BL.
    Semin Nucl Med; 2007 Sep; 37(5):316-31. PubMed ID: 17707239
    [Abstract] [Full Text] [Related]

  • 9. Monitoring cancer treatment with PET/CT: does it make a difference?
    Weber WA, Figlin R.
    J Nucl Med; 2007 Jan; 48 Suppl 1():36S-44S. PubMed ID: 17204719
    [Abstract] [Full Text] [Related]

  • 10. [The role of whole body 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the management of unknown primary tumors].
    Wu ZJ, Zhang YX, Wei H, Jia Q.
    Zhonghua Yi Xue Za Zhi; 2007 Aug 28; 87(32):2253-6. PubMed ID: 18001544
    [Abstract] [Full Text] [Related]

  • 11. The role of FDG-PET/CT imaging in head and neck malignant conditions: impact on diagnostic accuracy and patient care.
    Gordin A, Golz A, Keidar Z, Daitzchman M, Bar-Shalom R, Israel O.
    Otolaryngol Head Neck Surg; 2007 Jul 28; 137(1):130-7. PubMed ID: 17599580
    [Abstract] [Full Text] [Related]

  • 12. Ionising radiation-free whole-body MRI versus (18)F-fluorodeoxyglucose PET/CT scans for children and young adults with cancer: a prospective, non-randomised, single-centre study.
    Klenk C, Gawande R, Uslu L, Khurana A, Qiu D, Quon A, Donig J, Rosenberg J, Luna-Fineman S, Moseley M, Daldrup-Link HE.
    Lancet Oncol; 2014 Mar 28; 15(3):275-85. PubMed ID: 24559803
    [Abstract] [Full Text] [Related]

  • 13. Integrating PET and PET/CT into the risk-adapted therapy of lymphoma.
    Kasamon YL, Jones RJ, Wahl RL.
    J Nucl Med; 2007 Jan 28; 48 Suppl 1():19S-27S. PubMed ID: 17204717
    [Abstract] [Full Text] [Related]

  • 14. Clinical role of 18F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma.
    Quon A, Fischbein NJ, McDougall IR, Le QT, Loo BW, Pinto H, Kaplan MJ.
    J Nucl Med; 2007 Jan 28; 48 Suppl 1():58S-67S. PubMed ID: 17204721
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Impact of whole-body imaging on treatment decision to radio-frequency ablation in patients with malignant liver tumors: comparison of [18F]fluorodeoxyglucose-PET/computed tomography, PET and computed tomography.
    Kuehl H, Rosenbaum-Krumme S, Veit-Haibach P, Stergar H, Forsting M, Bockisch A, Antoch G.
    Nucl Med Commun; 2008 Jul 28; 29(7):599-606. PubMed ID: 18528181
    [Abstract] [Full Text] [Related]

  • 17. Imaging in multiple myeloma.
    Delorme S, Baur-Melnyk A.
    Eur J Radiol; 2009 Jun 28; 70(3):401-8. PubMed ID: 19272726
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 60.